A Snapshot of Five Contenders to Combat Infectious Diseases in the Post-Pandemic Landscape
Infectious disease is the focus of the biopharma track at INVEST Pitch Perfect May 20-21 in Chicago. Register today!
MeMed gets $9.2M to develop tools to distinguish between bacterial and viral infections
The ultimate goal of MeMed is to right-size antibiotic use. The team is working on a second-generation platform that gets results in minutes and that anyone can use.
Integrating GLP-1s: How Berry Street is Redefining Nutrition Care
Richard Fu details the company's approach to nutrition therapy and strategy for patients using GLP-1s.